tirzepatide phase 3 trial SURMOUNT‐4 study design. This is a 3, multicenter, randomized, Tirzepatide monotherapy in Chinese patients
Pay in 4 interest-free payments of $6.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16


01443-4/asset/1245bc8d-99c6-4ac1-b69b-8c0220ceb8fd/main.assets/gr1.jpg)























